Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy
NCT ID: NCT02643199
Last Updated: 2017-07-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2015-12-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
5D Versus Conventional 2D Fetal Echocardiography During Second Trimester of Pregnancy
NCT02675595
Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound
NCT02494440
Automated Folliculometry Using Five-Dimensional Ultrasound
NCT02642575
Trans-cerebellar Diameter and Placental Thickness in Third Trimesteric Pregnant Women for Calculation of Gestational Age
NCT04240041
Frequency of Performing Umbilical Artery Doppler in the Third Trimester in High Risk Pregnancy
NCT03584763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
90 pregnant women will be recruited from the Fetal Care Unit who will fulfill the inclusion criteria. They will be counseled to be included into the study.
All cases will be subjected to:
1. Full history taking including patient's age, parity, last menstrual period, estimated gestational age by dates, past history of medical disorders, clinical examinations (General and abdominal).
2. Two-Dimensional Ultrasound and Five-Dimensional Ultrasound will be done for all cases for assessment of fetal Heart.
* 90 consecutive patients will undergo 2D fetal echocardiography by one observer
* Then they will undergo blindly Five-Dimensional fetal echocardiography by another observer
* The data collected will be compared to evaluate the accuracy of Five-Dimensional US in fetal heart assessment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Gestational age at 34-36 weeks as determined be date and last menstrual period.
3. Normal Amniotic Fluid Index.
Exclusion Criteria
2. Oligohydramnios or Polyhydramnios (AFI \> 95th percentile or \< 5th percentile).
3. Obese patient, BMI \> 30
4. Intrauterine growth restriction.
5. Fetal spine between the 11- and 1- O'clock positions due to possibility of shadowing from ribs or spine
18 Years
38 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rehab Mohamed Abdelrahman
Lecturer of Obstetrics and Gynaecology Faculty of Medicine, Ain Shams University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5D Echocardiography
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.